1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain.

Chris Bladen, Vinicius M. Gadotti, Miyase G. Gündüz, N. Daniel Berger, Rahime Şimşek, Cihat Şafak, Gerald W. Zamponi

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

We have recently identified a class of dihydropyridine (DHP) analogues with 30-fold selectivity for T-type over L-type calcium channels that could be attributed to a modification of a key ester moiety. Based on these results, we examined a second series of compounds with similar attributes to determine if they had enhanced affinity for T-type channels. Whole-cell patch clamp experiments in transfected tsA-201 cells were used to screen these DHP derivatives for high affinity and selectivity for Cav3.2 over Cav1.2 L-type channels. The effects of the two lead compounds, termed N10 and N12, on Cav3.2 channel activity and gating were characterized in detail. When delivered intrathecally or intraperitoneally, these compounds mediated analgesia in a mouse model of acute inflammatory pain. The best compound from the initial screening, N12, was also able to reverse mechanical hyperalgesia produced by nerve injury. The compounds were ineffective in Cav3.2 null mice. Altogether, our data reveal a novel class of T-type channel blocking DHPs for potential pain therapies.
Original languageEnglish
Pages (from-to)1237-1247
Number of pages11
JournalPflugers Archiv European Journal of Physiology
Volume467
Issue number6
DOIs
Publication statusPublished - 1 Jun 2015
Externally publishedYes

Keywords

  • Calcium channels
  • 1,4-Dihydropyridine
  • Pain
  • L-type
  • T-type

Fingerprint Dive into the research topics of '1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain.'. Together they form a unique fingerprint.

  • Cite this